Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer by Takashi Ito, Hiromi Nagashima, Masachika Akiyama, Yu Utsumi, Hideomi Sato, Shinji Chiba, Mayu Sugai, Kenji Ube, Yoshiaki Mori, Kana Watanabe, Tatsuro Fukuhara, Makoto Maemondo

Get full text